Malignant hematological diseases

In this topical collection (17 articles)

1. Research article

   KIR repertory in patients with hematopoietic diseases and healthy family members

   Daniele Kazue Sugioka, Carlos Eduardo Ibaldo Gonçalves… Article:25

   Download PDF (708KB) View Article

2. Research article

   Evaluation and characterization of tumor lysis syndrome before and after chemotherapy among pediatric oncology patients in Tikur Anbessa specialized hospital, Addis Ababa, Ethiopia

   Haileleul Micho, Yasin Mohammed, Daniel Hailu, Solomon Genet Article:22

   Download PDF (752KB) View Article

3. Case report

   A new adult AML case with an extremely complex karyotype, remission and relapse combined with high hyperdiploidy of a normal chromosome set in secondary AML

   Abdulsamad Wafa, Suher ALmedania, Abdulmunim Aljapawe, Thomas Liehr… Article:21

   Download PDF (1827KB) View Article

4. Research article

   Rapid access clinic for unexplained lymphadenopathy and suspected malignancy: prospective analysis of 1000 patients

   Andrea Kühnl, David Cunningham, Margaret Hutka, Clare Peckitt… Article:19

   Download PDF (545KB) View Article

5. Case report

   Chronic Epstein Barr virus infection leading to classical Hodgkin lymphoma

   Nawid M. Sarwari, Joseph D. Khoury, Cristhiam M. Rojas Hernandez Article:19

   Download PDF (2118KB) View Article

6. Case report

   Mast cell leukemia associated with undefined morphology and chronic basophilic leukemia

   Cavit Cehreli, Inci Alacacioglu, Ozden Piskin, Halil Ates, Ruksan Cehreli… Article:17

   Download PDF (749KB) View Article

7. Research article

   A systematic review of using and reporting survival analyses in acute lymphoblastic leukemia literature

   Chatree Chai-Adisaksopha, Alfonso Iorio, Christopher Hillis, Wendy Lim… Article:17

   Download PDF (755KB) View Article

8. Study protocol

   The MUK five protocol: a phase II randomised, controlled, parallel group, multi-centre trial of carfilzomib, cyclophosphamide and dexamethasone (CCD) vs. cyclophosphamide, bortezomib (Velcade) and dexamethasone (CVD) for first relapse and primary refractory multiple myeloma

   Sarah Brown, Samantha Hinsley, Mónica Ballesteros, Sue Bourne… Article:14

   Download PDF (809KB) View Article

9. Study protocol

   Design and rationale of the QUAZAR Lower-Risk MDS (AZA-MDS-003) trial: a randomized phase 3 study of CC-486 (oral azacitidine) plus best supportive care vs placebo plus best supportive care in patients with IPSS lower-risk myelodysplastic syndromes and poor prognosis due to red blood cell transfusion–dependent anemia and thrombocytopenia

   Guillermo Garcia-Manero, Antonio Almeida, Aristoteles Giagounidis… Article:12

   Download PDF (555KB) View Article

10. Research article

    Kinetics of Langerhans cell chimerism in the skin of dogs following 2 Gy TBI allogeneic hematopoietic stem cell transplantation

    Sabrina Peters, Christian Junghanss, Anne Knueppel, Hugo Murua Escobar… Article:11

    Download PDF (1142KB) View Article

11. Research article

    Characteristics of chronic lymphocytic leukemia in Senegal

    Abibatou Sall, Awa Oumar Touré, Fatimata Bintou Sall, Moussa Ndour… Article:10

    Download PDF (814KB) View Article

12. Research article

    Patterns of bone marrow aspiration confirmed hematological malignancies in Eritrean National Health Laboratory

    Natnael Belai, Amon Solomon Ghebrenegus, Amin Ata Alamin, Ghirmay Embaye… Article:8

    Download PDF (334KB) View Article

13. Case report

    A case of multiple myeloma presenting as a distal renal tubular acidosis with extensive bilateral nephrolithiasis

    Chathuranga Lakmal Fonseka, Sampath Rukshani Galappaththi… Article:8

    Download PDF (570KB) View Article

14. Research article

    Response to Imatinib therapy is inferior for e13a2 BCR-ABL1 transcript type in comparison to e14a2 transcript type in chronic myeloid leukaemia

    Graeme Greenfield, Ross McMullan, Nuala Robson, Julie McGimpsey… Article:7

    Download PDF (1611KB) View Article

15. Research article

    A pilot study on the usefulness of peripheral blood flow cytometry for the diagnosis of lower risk myelodysplastic syndromes: the “MDS thermometer”

    Ana Aires, Maria dos Anjos Teixeira, Catarina Lau, Cláudia Moreira… Article:6

    Download PDF (2864KB) View Article

16. Commentary

    More is less, less is more, or does it really matter? The curious case of impact of azacitidine administration schedules on outcomes in patients with myelodysplastic syndromes

    Rory M. Shallis, Amer M. Zeidan Article:4

    Download PDF (382KB) View Article

17. Research article

    Systematic review of azacitidine regimens in myelodysplastic syndrome and acute myeloid leukemia

    Roman M. Shapiro, Alejandro Lazo-Langner Article:3

    Download PDF (661KB) View Article